FReSH-43597-en
The Concept of Self and Autobiographical Memory in the Care of Patients with Alcohol Use Disorder: A Pilot Study
COSMAb
| Name | Country code |
|---|---|
| France | fr |
In 2015, an estimated 41,000 deaths in France were attributed to alcohol consumption, accounting for 7% of deaths among people aged 15 and older and representing the second leading cause of preventable mortality (Bonaldi & Hill, 2019). The primary victims are patients with Alcohol Use Disorder (AUD). Managing this chronic and complex condition requires consideration of numerous biological, psychological, and social factors. In this context, one of the factors highlighted in understanding alcohol consumption behavior is the Alcohol-Related Self-Concept (ARSC; Lindgren et al., 2017). A recent meta-analysis has shown that the ARSC is a robust predictor of alcohol consumption behavior and associated problems (Montes & Pearson, 2021). However, studies in the field of autobiographical memory have shown that it underlies the construction of the self-concept. Indeed, this form of memory stores all the information and memories specific to an individual accumulated since childhood, which enable them to construct a sense of identity and temporal continuity. According to the model proposed by Conway and Pleydell-Pearce (2000), autobiographical memories serve as the building blocks that help individuals construct a coherent self-image and update their self-concept. However, data from the literature have shown that AM is particularly impaired in patients with ALD (Cuervo-Lombard et al. 2016; Nandrino & Gandolphe, 2017). In line with the concepts of Nandrino, Gandolphe & El Haj (2017), we hypothesize that autobiographical memory could serve as a therapeutic lever toward the CSA.
['Clinical data','Socio-demographic data','Behavioral data','Participant-reported health data']
Individus
| Topic | Vocabulary |
|---|---|
| Addiction medicine | health theme |
| Psychiatry | health theme |
| Alcohol dependence | cim-11 |
| Behavioral determinants | health determinant |
| Behavioral determinants: Addiction | health determinant |
['Grand Est']
{
"level_sex_clusion_I": [
{
"concept": {
"vocab": "MeSH",
"vocabURI": "D005260"
},
"value": "Female"
},
{
"concept": {
"vocab": "MeSH",
"vocabURI": "D008297"
},
"value": "Male"
}
],
"level_age_clusion_I": [
{
"concept": {
"vocab": "MeSH",
"vocabURI": "D000328"
},
"value": "Adult (25 to 44 years)"
},
{
"concept": {
"vocab": "MeSH",
"vocabURI": "D008875"
},
"value": "Middle Aged (45 to 64 years)"
}
],
"level_type_clusion_I": "Patients population",
"level_type_clusion_other": "",
"clusion_I": "- Patients aged 18 or older, male or female, who were either hospitalized or receiving outpatient care at the time of enrollment.\r\n- Diagnosis of a current alcohol use disorder, according to the diagnostic criteria in the DSM-5-TR.\r\n- Native French speaker, able to read and write fluently in French (based on personality questionnaires and cognitive tests).\r\n- Voluntary participation, following review of the information sheet describing the study and written agreement to participate by signing the informed consent form.\r\n",
"clusion_E": "Exclusion criteria:\r\n- Diagnosis of active and unstable psychiatric disorders, based on the DSM-5-RT diagnostic criteria.\r\n- Presence of moderate or severe substance use disorders according to DSM-5-TR criteria (excluding tobacco).\r\n- A diagnosis of intellectual disability or pervasive developmental disorder.\r\n- Presence of any clinically significant or unstable condition: organic disorders affecting the central nervous system or conditions likely to interfere with assessments, including neurological complications of alcoholism.\r\n- Presence of uncorrected sensory impairments (vision and hearing) due to the perceptual-visual nature of certain cognitive tests.\r\n- Persons who are specifically protected under Articles L.1121-5 through L.1121-8 of the French Public Health Code.\r\n\r\nExclusion criteria:\r\n- Patients with cognitive impairment (Montreal Cognitive Assessment [MoCA] score < 22 at baseline).\r\n"
}
| Name |
|---|
| Fabien;GIERSKI |
| Name | Role |
|---|---|
| EPSM Marne | sponsor |
| UNIVERSITE DE REIMS CHAMPAGNE-ARDENNE (URCA) | sponsor |
| Name |
|---|
| GIS-INSTITUT POUR LA RECHERCHE EN SANTE PUBLIQUE (IRESP) |
| EPSM Marne |
| UNIVERSITE DE REIMS CHAMPAGNE-ARDENNE (URCA) |
| Name |
|---|
| Christine-Vanessa;CUERVO-LOMBARD |
| UNIVERSITE DE TOULOUSE |
| Jessica;MANGE |
| UNIVERSITE DE CAEN NORMANDIE |
| Universities of Reims Champagne-Ardenne, University of Toulouse Jean-Jaurès, University of Caen Normandy |
| Agency name |
|---|
| CPP |
['Through organizations (health services or institutions, schools, businesses, etc.)']
['{"concept":{"vocab":"CESSDA","vocabURI":"Nonprobability"},"value":"Non-probability"}','{"concept":{"vocab":"CESSDA","vocabURI":"Nonprobability.Availability"},"value":"Non-probability: Availability (convenience or opportunity sampling)"}']
Interventional Study
| Start | End |
|---|---|
| 2025-05-28 | 2027-11-27 |
3 measurements: at M0, M3, and M6
| Name | |
|---|---|
| Fabien;GIERSKI | fabien.gierski@univ-reims.fr |
Yes
No
{"extLink":{"title":"COAR","uri":""},"value":"To be defined"}
| Indicate if special permissions are required to access a resource |
|---|
| No |
| Name | |
|---|---|
| Fabien;GIERSKI | fabien.gierski@univ-reims.fr |
FReSH-43597-en
| Name |
|---|
| Fabien GIERSKI |